130 related articles for article (PubMed ID: 28667739)
1. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
Essers BAB; Arits AH; Hendriks MR; Mosterd K; Kelleners-Smeets NW
Br J Dermatol; 2018 Jan; 178(1):e26-e27. PubMed ID: 28667739
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
Fink-Puches R; Wolf P; Kerl H
Arch Dermatol; 1997 Dec; 133(12):1494-5. PubMed ID: 9420532
[No Abstract] [Full Text] [Related]
3. Cells to Surgery Quiz: July 2018.
Neal DE; Smith RJ; Aberbigbe O; Etzkorn JR
J Invest Dermatol; 2018 Jul; 138(7):e49. PubMed ID: 29941100
[No Abstract] [Full Text] [Related]
4. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
6. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
Nijsten T
Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
[No Abstract] [Full Text] [Related]
7. Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient.
Perrett CM; Tan SK; Cerio R; Goldsmith PC; McGregor JM; Proby CM; Harwood CA
Clin Exp Dermatol; 2006 Jan; 31(1):146-7. PubMed ID: 16309518
[No Abstract] [Full Text] [Related]
8. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW
Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis.
Foley P
Australas J Dermatol; 2005 Feb; 46 Suppl 3():S8-10; discussion S23-5. PubMed ID: 15859301
[No Abstract] [Full Text] [Related]
10. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
Arits A; Nelemans P; Kelleners-Smeets N
Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
[No Abstract] [Full Text] [Related]
11. Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.
Hambly R; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Br J Dermatol; 2017 Sep; 177(3):e55-e57. PubMed ID: 28028807
[No Abstract] [Full Text] [Related]
12. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
13. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with basal cell carcinoma after successful treatment with intralesional photodynamic therapy.
Suárez Valladares MJ; Pérez Paredes MG; González Sixto B; Rodríguez Prieto MÁ
J Am Acad Dermatol; 2016 Dec; 75(6):e247. PubMed ID: 27846979
[No Abstract] [Full Text] [Related]
15. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
van Delft LCJ; Nelemans PJ; Jansen MHE; Arits AHMM; Roozeboom MH; Hamid MA; Mosterd K; Kelleners-Smeets NWJ
J Am Acad Dermatol; 2019 Apr; 80(4):1022-1028. PubMed ID: 30582993
[TBL] [Abstract][Full Text] [Related]
16. Treating basal-cell carcinoma in a real life setting.
Dummer R
Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
[TBL] [Abstract][Full Text] [Related]
18. Effect of pigmentation on photodynamic therapy.
Apalla Z; Lallas A; Sotiriou E; Ioannides D
Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
[No Abstract] [Full Text] [Related]
19. Rapid progression of a basal cell carcinoma after photodynamic therapy.
Karen JK; Hale EK
Dermatol Surg; 2010 Aug; 36(8):1328-31. PubMed ID: 20584044
[No Abstract] [Full Text] [Related]
20. Sequential treatment of giant basal cell carcinomas.
Madan V; West CA; Murphy JV; Lear JT
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
